. Author manuscript; available in PMC: 2008 Feb 3.

Published in final edited form as: Eur J Pharmacol. 2007 Jun 9;569(1-2):48–58. doi: 10.1016/j.ejphar.2007.05.055

Table 1.

Initial and final body weights and blood glucose concentrations in control mice and diabetic mice with and without the peroxynitrite decomposition catalyst FP15 treatment

	Body weight (g)		Blood glucose (mmol/l)
	Initial	Final	Initial	Final
Control	20.6±0.40	29±0.95	7.9±0.17	8.0±0.2
Control+FP15	19.8±0.33	27±0.81	8±0.2	7.9±0.12
Diabetic	20±0.3	25±0.5^a	14.4±0.7^a	33±0.2^a
Diabetic+FP15	20.8±0.35	24.4±0.4^a	14.7±1.0^a	32.4±0.5^a

Data are means±SEM, n=9–11 per group.

Significantly different from controls (p<0.01).